Pfizer also said it is working to improve its existing vaccine formulation, developed jointly with Germany's BioNTech, based on the vaccine's reaction to new COVID-19 variants that arise.

A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.

Full approval means Pfizer's COVID-19 vaccine meets the same “very high standards required of all the approved vaccines we rely on every day,” said Dr. Jesse Goodman of Georgetown University ...

O n Aug. 23, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine, one made by Pfizer-BioNTech, for anyone 16 years and older.

The Food and Drug Administration has authorized booster shots of the Pfizer and BioNTech COVID-19 vaccine for 16- and 17-year-olds, the agency announced Thursday. Previously, only adults ages 18 an… ...

The coronavirus shots, made by Pfizer and its German partner BioNTech, are among 10 possible vaccine candidates in late-stage testing around the world — four of them so far in huge studies in ...

Pfizer is also looking to expand its vaccine business following the pandemic, extending its use of the gene-based mRNA technology which has proved highly effective in the Covid-19 vaccines.

To get more people vaccinated against Covid-19, it could be beneficial for the FDA to consider approving Pfizer’s vaccine before authorizing a booster shot, Dr. Carlos del Rio, executive ...

Pfizer said research showed booster doses of its vaccine, developed with BioNTech, produced levels of neutralizing antibodies that are five to 10 times higher than what’s produced after two doses.

On Monday, the U.S. pharmaceutical giant Pfizer and its German partner, BioNTech SE, said that early analysis show that the Covid-19 vaccine is more than 90 percent effective at preventing ...

A leading coronavirus vaccine candidate developed by Pfizer and BioNTech will be submitted for regulatory approval "within days," the companies announced Wednesday, after their final analysis ...

Pfizer and Moderna have both announced that they have produced vaccines that are more than 90% effective at preventing COVID-19. Barring unexpected obstacles, health care workers and people at ...